CSIMarket
 
Omeros Corporation  (NASDAQ: OMER)
 

Omeros's Suppliers Performance

OMER's Supply Chain




 
OMER Costs vs Sales of Suppliers Growth Omeros's cost of sales deteriorated by 0 % year on year, sequentially cost of sales grew by 35.95 % in Q2.

More on OMER Suppliers



Omeros's cost of sales deteriorated by 0 % year on year, sequentially cost of sales grew by 35.95 % in Q2.

More on OMER Suppliers




Omeros's Comment on Supply Chain


Suppliers and contract manufacturers are required to comply with regulatory requirements before and after product approval. These include establishing pharmacovigilance systems, reporting adverse reactions and production issues, and adhering to advertising and promotion regulations. They may also be subject to additional obligations such as enhanced safety monitoring, clinical trials, post-marketing safety studies, or Risk Evaluation and Mitigation Strategies (REMS) restrictions. Quality control and manufacturing processes must continuously conform to current Good Manufacturing Practice (cGMP) standards. Maintaining regulatory compliance necessitates ongoing investment in production and quality control. Safety concerns identified after approval can result in labeling changes, usage restrictions, or product withdrawal from the market.

Omeros's Comment on Supply Chain


Suppliers and contract manufacturers are required to comply with regulatory requirements before and after product approval. These include establishing pharmacovigilance systems, reporting adverse reactions and production issues, and adhering to advertising and promotion regulations. They may also be subject to additional obligations such as enhanced safety monitoring, clinical trials, post-marketing safety studies, or Risk Evaluation and Mitigation Strategies (REMS) restrictions. Quality control and manufacturing processes must continuously conform to current Good Manufacturing Practice (cGMP) standards. Maintaining regulatory compliance necessitates ongoing investment in production and quality control. Safety concerns identified after approval can result in labeling changes, usage restrictions, or product withdrawal from the market.







OMER's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Omeros Corporation 1,829.26 0.00 124.83 175
SUBTOTAL 0.00 0.00 0.00 -


Sources: Omeros Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Omeros Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.